In HNSCC, the activity of EZH2 may be enhanced by phosphorylation at the serine 21 site, which leads to direct binding and methylation of signal transducer and activator of transcription factor 3 (STAT3). This evidence concerns the gene EZH2 and head and neck squamous cell carcinoma.